WebDisclosure WebDisclosure
Basculer en Français
10935 Companies
238770 Keywords
167618 Articles
128332 Press releases
Headlines Articles Press releases NLS Pharmaceutics AG Remove
  1. Home
  2. Companies
  3. NLS Pharmaceutics AG
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 08/28/2023 at 13:30, 3 years ago

    NLS Pharmaceutics CEO Issues Letter to Shareholders

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 05/02/2023 at 14:45, 3 years 4 months ago

    NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 03/27/2023 at 14:30, 3 years 5 months ago

    NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/23/2023 at 14:30, 3 years 7 months ago

    NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/12/2023 at 14:30, 3 years 7 months ago

    NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds

    Logo of NLS Pharmaceutics AG
Accesswire
  • Published on 09/04/2026 at 14:30, 3 hours 39 minutes ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

  • Published on 09/04/2026 at 14:00, 4 hours 9 minutes ago

    Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair

  • Published on 09/04/2026 at 13:30, 4 hours 39 minutes ago

    Suntex Enterprises Launches Ambitious $1 Billion+ North American Real Estate Development Initiative

  • Published on 09/04/2026 at 13:00, 5 hours 9 minutes ago

    Storm Further Upsizes Private Placement to $3.2M

  • Published on 09/04/2026 at 08:02, 10 hours 7 minutes ago

    Southern Energy Corp. Announces Restricted Share Award Grant

View all ACCESSWIRE
EQS Group
  • Published on 09/04/2026 at 17:50, 18 minutes ago

    CHiQ at IFA 2026: From Global Expansion to Deeper Local Engagement

  • Published on 09/04/2026 at 17:40, 29 minutes ago

    BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 31.08.26.

  • Published on 09/04/2026 at 17:05, 1 hour 3 minutes ago

    Hisense Brings True-to-Life Color, Eye Comfort and Immersive Entertainment to IFA 2026

  • Published on 09/04/2026 at 16:50, 1 hour 18 minutes ago

    VEVOR Steps Offline in Europe at IFA Berlin 2026, with First European Store Planned in France for 2027

  • Published on 09/04/2026 at 16:30, 1 hour 38 minutes ago

    BLUETTI, BSW-Solar, Shelly Group and Flatpeak Bring Industry Voices Together at IFA 2026 to Shape the Future of Smarter Energy

View all EQS
Les Echos
  • Published on 09/04/2026 at 18:00, 9 minutes ago

    Déclaration des droits de vote à fin août 2026

  • Published on 09/04/2026 at 18:00, 9 minutes ago

    Information relative au nombre total des droits de vote et d’actions composant le capital social

  • Published on 09/04/2026 at 17:45, 24 minutes ago

    Declaration of voting rights at the end of August 2026

  • Published on 09/04/2026 at 17:45, 24 minutes ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 09/04/2026 at 17:45, 24 minutes ago

    DECLARATION D’ACTIONS ET DE DROITS DE VOTE

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy